Video Channel

New Advances Provide Hope for Alzheimer’s Patients

Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer’s disease clinical trials, led a five-year review of all Alzheimer’s drugs in the development pipeline. He says today there is more hope than ever that we’ll one day solve Alzheimer’s.

The paper, “Alzheimer’s disease drug development pipeline: 2020,” was published this week in the journal Alzheimer’s & Dementia: Translational Research & Clinical Interventions.

Full Story